KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CDNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for CareDx as stock downgraded to Strong Sell Candidate.
(Updated on Apr 26, 2024)

Sell candidate since Apr 03, 2024 Loss -24.70% PDF

No changes to the price of CareDx stock on the last trading day (Friday, 26th Apr 2024). During the last trading day the stock fluctuated 5.66% from a day low at $7.42 to a day high of $7.84. The price has fallen in 6 of the last 10 days and is down by -11.37% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $7.55 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.98% during the next 3 months and, with a 90% probability hold a price between $7.33 and $11.50 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CDNA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The CareDx stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.98 and $9.45. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for CareDx stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.420 between high and low, or 5.66%. For the last week, the stock has had daily average volatility of 5.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CDNA) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect CareDx to open at $7.61, and during the day (based on 14 day Average True Range), to move between $7.02 and $8.10, which gives a possible trading interval of +/-$0.537 (+/-7.10%) up or down from last closing price. If CareDx takes out the full calculated possible swing range there will be an estimated 14.20% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $8.23, some $0.670 (8.86%) from the current price of $7.56, our system finds the risk reward not very attractive.

Is CareDx stock A Buy?

CareDx holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.070 Strong Sell Candidate Downgraded

Predicted Opening Price for CareDx of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$7.61 ( 0.617%) $7.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CDNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.03 6.17 %
R2 7.87 4.05 %
R1 7.77 2.74 %
Current price: 7.56
Support S1 7.45 -1.50 %
S2 7.35 -2.82 %
S3 7.19 -4.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.56 13.23 %
R2 8.28 9.52 %
R1 8.23 8.86 %
Current price 7.56
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for CareDx Stock and on which exchange is it traded?
The symbol for CareDx is CDNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CareDx Stock?
CareDx holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy CareDx Stock?
CareDx Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CareDx Stock.

What's the current price of CareDx Stock?
As of the end of day on the Apr 26, 2024, the price of an CareDx (CDNA) share was $7.56.

What is the 52-week high and low for CareDx Stock?
The 52-week high for CareDx Stock is $12.91 and the 52-week low is $4.80.

What is the market capitalization of CareDx Stock?
As of the Apr 26, 2024, the market capitalization of CareDx is 391.445M.

When is the next earnings date for CareDx?
The upcoming earnings date for CareDx is May 08, 2024.
Click to get the best stock tips daily for free!

About CareDx

CareDx CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The co... CDNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT